CCN1 and laryngotracheoesophageal cleft: However, this proof‐of‐principle finding needs to be verified in larger study groups of LC patients, including nontumorous lung diseases which could lead to false‐positive signals since it was previously reported that CYR61 is elevated in asbestos‐associated diseases as well [31].